Article info
Review
Lights on HBME-1: the elusive biomarker in thyroid cancer pathology
- Correspondence to Dr Giorgio Cazzaniga, Università degli Studi di Milano-Bicocca, Milano, Lombardia, Italy; g.cazzaniga18{at}campus.unimib.it
Citation
Lights on HBME-1: the elusive biomarker in thyroid cancer pathology
Publication history
- Received February 23, 2022
- Accepted March 31, 2022
- First published April 20, 2022.
Online issue publication
November 15, 2022
Article Versions
- Previous version (15 November 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.